OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.
Carter
Natalie J
NJ
Adis, a Wolters Kluwer Business, North Shore, Auckland, New Zealand. demail@adis.co.nz
Keating
Gillian M
GM
D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004347:Drug Interactions; D006801:Humans; D004091:Hydromorphone / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015394:Molecular Structure; D010146:Pain / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D004091:Hydromorphone